City

Atlanta (1)

Bethesda (1)

Condition

Infection Due to Resistant Organism (3)

Overall Status

No longer available (1)

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Emory University (1)

U.S. Army Medical Research and Development Command (1)

University of Miami (1)

Collaborator

Cepheid (1)

Meiji Seika Pharma Co., Ltd. (1)

Uniformed Services University of the Health Sciences (1)

Intervention

arbekacin sulfate (1)

bowel preparation (1)

fasting (1)

fecal microbiota transplant (fmt) (1)

openbiome fecal microbiota transplantation retention enema (1)

stool or perirectal swab sampling (1)

Study Documents

Intervention Type

biological (2)

drug (1)

other (1)

procedure (1)

Funder Type

Other (2)

U.S. Fed (1)

Study Type

Interventional (2)

Expanded Access (1)

infection due to resistant organism

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Infection Due to Resistant Organism Trial in Atlanta (biological, procedure, other)

Recruiting

Infection Due to Resistant Organism

Fecal Microbiota Transplant (FMT)
+3 more

Atlanta, Georgia

Emory University Hospital

Oct 9, 2021

Infection Due to Resistant Organism Trial (OpenBiome Fecal Microbiota Transplantation retention enema)

Withdrawn

Infection Due to Resistant Organism

OpenBiome Fecal Microbiota Transplantation retention enema

(no location specified)

May 21, 2020

Infection Due to Resistant Organism Trial run by the (Arbekacin Sulfate)

No longer available

Infection Due to Resistant Organism

Arbekacin Sulfate

Bethesda, Maryland

Walter Reed National Military Medical Center (WRNMMC)

Dec 30, 2019